In case you missed it: November 7 to November 11
A look back at the week's headlines.
A wave of change: How EMIGS is altering the surgical training landscape
Nash Moawad, MD, MS, FACOG, FACS, sits down to discuss the recent standardization of Essentials of Minimally Invasive Gynecologic Surgery (EMIGS) training program for minimally invasive gynecologic surgeons and how it's shaping the way this subspecialty delivers care.
November is for diabetes awareness
November is Diabetes Awareness Month.
2023 women's health outlook
Alison Cowan, MD, discusses her predictions for women's health trends in 2023.
Inside the November issue of Contemporary OBGYN
Take a look inside this month's issue.
Efficacy of N. sativa-honey vs. clotrimazole for VVC
A study published in the journal Evidence-Based Complementary and Alternative Medicine found that both Nigella sativa (N. sativa) (black seed and black cumin)-honey vaginal cream and the antifungal medication clotrimazole significantly improve the symptoms of vulvovaginal candidiasis (VVC).
Highlights from the 25th Annual Premier Women’s Healthcare Conference
Houston, Texas, was buzzing with the latest updates in women’s health at the 25th Annual Nurse Practitioners in Women’s Health Premier Women’s Healthcare Conference held from September 29 to October 2, 2022.
Readers React: Neutral language has adverse effects
A reader writes in to the editors.
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
